Please log in to save bookmarks. Only registered users can save their favorite pages.
Journal Properties
Continued as
Drug Research
Language
English, German
Number of Articles
1,944
ISSN
0004-4172
e-ISSN
1616-7066
Main Publisher
Editio Cantor Verlag GmbH
Publisher
Georg Thieme Verlag KG
Indian UGC
Indian UGC Name
DOAJ (latest)
Description
Arzneimittelforschung (Drug Research) is a peer-reviewed journal dedicated to the publication of original research in the fields of drug development, pharmacology, and clinical research. It presents cutting edge findings with focus on innovative therapies. First 150 characters gives a summary of journal's focus on drug research.
It provides a platform for scientists to disseminate their work on drug synthesis, preclinical and clinical studies, and pharmaceutical technology. Key topics covered include pharmacology, toxicology, clinical trials, and pharmaceutical chemistry. The journal indexes in major scientific databases, ensuring a broad reach to researchers, clinicians, and industry professionals worldwide. It particularly appeals to those seeking comprehensive insights into drug research.
Arzneimittelforschung serves as an essential resource for staying informed about the latest advancements in pharmaceutical sciences. Researchers are encouraged to submit their high-quality manuscripts, contributing to the journal's reputation for excellence in drug research. The journal emphasizes ethical and rigorous research practices, fostering the development of innovative therapies for the benefit of global health. With a long-standing history and commitment to quality, this journal remains a key publication in the field.